Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has appointed three new members to its Scientific Advisory Board: Dr. Andrea Califano, Dr. Arnold J. Levine and Dr. Aviv Regev.

Dr. Califano is the founding chairman of the department of systems biology at Columbia University, and he currently serves on the board of scientific advisors of the National Cancer Institute. He is also professor of biomedical informatics at Columbia University.

Dr. Levine is professor emeritus of systems biology at the Institute for Advanced Study in Princeton, N.J. and professor of pediatrics and of biochemistry with the Robert Wood Johnson Medical School at Rutgers, the State University of New Jersey.

Dr. Regev is a core member of the Broad Institute and an associate professor of biology at the Massachusetts Institute of Technology. She is also an investigator at the Howard Hughes Medical Institute.

"As pioneers in their fields of study, Andrea, Arnold and Aviv are strong additions to our Scientific Advisory Board," said Marc N. Casper, president and chief executive officer of Thermo Fisher. "They bring a depth of understanding from the academic and research communities that will help inform our strategies for advancing our customers' work in computational and systems biology, genomics and cancer research."

The Scientific Advisory Board, established in 2010 to formalize the two-way exchange of technological information between the company and representatives from some of the world's premier centers of health, science, and education, also includes the following members:

> Tyler Jacks, PhD, David H. Koch Professor of Biology and Director of the David H. Koch Institute for Integrative Cancer Research at MIT, and Investigator at the Howard Hughes Medical Institute (also a member of Thermo Fisher's Board of Directors)